Cynthia Balog-Alvarez

Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy

Sharla M. Birch, Michael W. Lawlor, Thomas J. Conlon et al. · Science Translational Medicine · 2023 · 68 citations · Full text

Medicine, Molecular Genetics, Molecular Medicine +16

Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy

Sara Mata López, Cynthia Balog-Alvarez, Stanislav Vitha et al. · PLoS ONE · 2020 · 35 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

Non-Targeted Metabolomics Analysis of Golden Retriever Muscular Dystrophy-Affected Muscles Reveals Alterations in Arginine and Proline Metabolism, and Elevations in Glutamic and Oleic Acid In Vivo

Muhammad Abdullah, Joe N. Kornegay, Aubree Honcoop et al. · Metabolites · 2017 · 34 citations · Full text

Life Sciences, Biochemistry, Molecular Medicine +17

Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures

Joe N. Kornegay, Daniel J. Bogan, Janet R. Bogan et al. · Skeletal Muscle · 2016 · 29 citations · Full text

Medicine, Veterinary Physiology, Regenerative Medicine +14

Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy

Sarah M. Schneider, Vidya Sridhar, Amanda K. Bettis et al. · Molecular Imaging and Biology · 2018 · 27 citations · Full text

Life Sciences, Biochemistry, Veterinary Clinical Sciences +17